[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.92.62. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Health Agencies Update
January 15, 2003

Supplement Enforcement Tightened

JAMA. 2003;289(3):290. doi:10.1001/jama.289.3.290-a

At a December press briefing, the Food and Drug Administration (FDA) announced the seizure of 3000 bottles of EverCLR, a dietary supplement marketed by Halo Supply Company of San Diego, Calif, in what the agency called an "example of its commitment to strong enforcement . . . of unapproved drug claims." The product was sold as a treatment for herpesvirus and protection from colds and influenza.

The move comes shortly after the US Court of Appeals for the District of Columbia Circuit restricted the FDA's authority to regulate dietary supplement claims. Observers said the raid was an attempt to send a clear signal about the types of claims that remain off-limits.

First Page Preview View Large
First page PDF preview
First page PDF preview
×